Search - tctmd.com

Displaying 601 - 620 of 9101

Sort: Relevancy | Date

Presentation TCT 2024

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

Presenter: Pamela Ropski

October 29, 2024

Presentation TCT 2024

Case 3: TR in the Setting of Advanced LV Dysfunction – Finding the Sweet Spot

Presenter: Michael Brener

October 29, 2024

Presentation TCT 2024

Case 2: TTVI in Pulmonary Hypertension – Where Do We Draw the Line for Interventional Treatment?

Presenter: Laura Davidson

October 29, 2024

Presentation TCT 2024

Case 1: TTVI in Lead Induced TR: Assessment and Management

Presenter: Julia Grapsa

October 29, 2024

Presentation TCT 2024

The Trisol TTVR System: Technology Differentiation and Early Clinical Experience

Presenter: Isaac George

October 29, 2024

Presentation TCT 2024

The Topaz TTVR System: Technology for Expanded Access and EFS Update

Presenter: Hendrik Treede

October 29, 2024

Presentation TCT 2024

The MonarQ TTVR First-in-Human Experience

Presenter: Arshad Quadri

October 29, 2024

Presentation TCT 2024

The Laplace TTVR System

Presenter: Pradeep Yadav

October 29, 2024

Presentation TCT 2024

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Presenter: Didier Tchetche

October 29, 2024

Presentation TCT 2024

The LuX-Valve Plus Transjugular TTVR System: One-Year Outcomes of a Multicenter Clinical Study in High Surgical Risk TR Patients

Presenter: Juan Granada

October 29, 2024

Presentation TCT 2024

The Intrepid TTVR Clinical Program

Presenter: Firas Zahr

October 29, 2024

Presentation TCT 2024

The Cardiovalve TTVR Clinical Program

Presenter: Christian Frerker

October 29, 2024

Presentation TCT 2024

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Presenter: Torsten Vahl

October 29, 2024

Presentation TCT 2024

TCT 97: A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope

Presenter: Ricky E Lemus-Zamora

October 29, 2024

Presentation TCT 2024

TCT 789: Sex-Specific Outcomes of Valve-in-Valve Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

October 29, 2024

Presentation TCT 2024

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

Presenter: José Antonio Baz Alonso

October 29, 2024

Presentation TCT 2024

TCT 1543: Combined Apical Left Ventricular Thrombus Removal With Concomitant Ventricular Tachycardia Ablation

Presenter: Rashid Alhusain

October 29, 2024

Presentation TCT 2024

TCT 1519: Virtual Reality Revolutionizing Structural Cardiology: Pre-Procedural ASD Closure Done in a 3D Model

Presenter: Pablo Barzallo

October 29, 2024

Presentation TCT 2024

TCT 1492: Clot Chase

Presenter: Rishi Sukhija

October 29, 2024

Presentation TCT 2024

TCT 1475: Challenging Patent Foramen Ovale Closure

Presenter: Sheraz Hussain

October 29, 2024

Advertisement

TCT 823: Association Between Sodium-Glucose Co-Transporter 2 Inhibitor Use and Renal Function After Transcatheter Aortic Valve Replacement: A Retrospective Matched Cohort Analysis

Case 3: TR in the Setting of Advanced LV Dysfunction – Finding the Sweet Spot

Case 2: TTVI in Pulmonary Hypertension – Where Do We Draw the Line for Interventional Treatment?

Case 1: TTVI in Lead Induced TR: Assessment and Management

The Trisol TTVR System: Technology Differentiation and Early Clinical Experience

The Topaz TTVR System: Technology for Expanded Access and EFS Update

The MonarQ TTVR First-in-Human Experience

The Laplace TTVR System

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

The LuX-Valve Plus Transjugular TTVR System: One-Year Outcomes of a Multicenter Clinical Study in High Surgical Risk TR Patients

The Intrepid TTVR Clinical Program

The Cardiovalve TTVR Clinical Program

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

TCT 97: A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope

TCT 789: Sex-Specific Outcomes of Valve-in-Valve Transcatheter Aortic Valve Implantation

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

TCT 1543: Combined Apical Left Ventricular Thrombus Removal With Concomitant Ventricular Tachycardia Ablation

TCT 1519: Virtual Reality Revolutionizing Structural Cardiology: Pre-Procedural ASD Closure Done in a 3D Model

TCT 1492: Clot Chase

TCT 1475: Challenging Patent Foramen Ovale Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content